Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy
Clinical trial NCT03664921 · COMPLETED
Trial details
- NCT number
- NCT03664921
- Sponsor
- Syntrix Biosystems, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2020-08-17
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.